Reducing the average number of patients needed in a phase II trial through novel design (2013)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3109/10601333.2013.854802
Publication URI: http://dx.doi.org/10.3109/10601333.2013.854802
Type: Journal Article/Review
Parent Publication: Clinical Research and Regulatory Affairs
Issue: 4
ISSN: 10601333 15322521